Clotrimazole preferentially inhibits human breast cancer cell proliferation, viability and glycolysis

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Furtado, Cristiane M ^a   Marcondes, Mariah C ^a   Sola Penna, Mauro ^a   de Souza, Maisa L S ^b   Zancan, Patricia ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO FEDERAL DE EDUCAÇÃO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ADENOSINE TRIPHOSPHATE; CLOTRIMAZOLE; GLUCOSE; HEXOKINASE; PYRUVATE KINASE; ANTINEOPLASTIC AGENT;

ARTICLE; BREAST CANCER; CANCER CELL; CELL LINEAGE; CELL MOTILITY; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; GLUCOSE TRANSPORT; GLYCOLYSIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; METABOLIC INHIBITION; MIGRATION INHIBITION; BREAST TUMOR; CELL MOTION; CELL SURVIVAL; DRUG EFFECT; FEMALE; METABOLOME; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CLOTRIMAZOLE; FEMALE; GLYCOLYSIS; HUMANS; METABOLOME;

EID: 84856692165     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030462     Document Type: Article

References (53)

1. Marin-Hernandez A, Rodriguez-Enriquez S, Vital-Gonzalez PA, Flores-Rodriguez FL, Macias-Silva M, et al. (2006) Determining and understanding the control of glycolysis in fast-growth tumor cells. Flux control by an over-expressed but strongly product-inhibited hexokinase. FEBS J 273: 1975-1988.
2. Meadows AL, Kong B, Berdichevsky M, Roy S, Rosiva R, et al. (2008) Metabolic and morphological differences between rapidly proliferating cancerous and normal breast epithelial cells. Biotechnol Prog 24: 334-341.
3. Hsu PP, Sabatini DM, (2008) Cancer Cell Metabolism: Warburg and Beyond. Cell 134: 703-707.
4. Gillies RJ, Robey I, Gatenby RA, (2008) Causes and consequences of increased glucose metabolism of cancers. J Nucl Med 49 (Suppl 2): 24S-42S.
5. Vander Heiden MG, Cantley LC, Thompson CB, (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033.
6. Almeida A, Bolanos JP, Moncada S, (2010) E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation. Proc Natl Acad Sci U S A 107: 738-741.
7. Lee HC, Wei YH, (2009) Mitochondrial DNA instability and metabolic shift in human cancers. Int J Mol Sci 10: 674-701.
8. Khalid MH, Tokunaga Y, Caputy AJ, Walters E, (2005) Inhibition of tumor growth and prolonged survival of rats with intracranial gliomas following administration of clotrimazole. J Neurosurg 103: 79-86.
9. Majewski N, Nogueira V, Bhaskar P, Coy PE, Skeen JE, et al. (2004) Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell 16: 819-830.
10. Glass-Marmor L, Beitner R, (1997) Detachment of glycolytic enzymes from cytoskeleton of melanoma cells induced by calmodulin antagonists. EurJPharmacol 328: 241-248.
11. Penso J, Beitner R, (2002) Detachment of glycolytic enzymes from cytoskeleton of Lewis lung carcinoma and colon adenocarcinoma cells induced by clotrimazole and its correlation to cell viability and morphology. MolGenetMetab 76: 181-188.
12. Meira DD, Marinho-Carvalho MM, Teixeira CA, Veiga VF, Da Poian AT, et al. (2005) Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes. MolGenetMetab 84: 354-362.
13. Sola-Penna M, Da Silva D, Coelho WS, Marinho-Carvalho MM, Zancan P, (2010) Regulation of mammalian muscle type 6-phosphofructo-1-kinase and its implication for the control of the metabolism. IUBMB Life 62: 791-796.
14. Warburg O, (1956) On the origin of cancer cells. Science 123: 309-314.
15. Zancan P, Sola-Penna M, Furtado CM, Da Silva D, (2010) Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells. Mol Genet Metab 100: 372-378.
16. Geschwind JF, Ko YH, Torbenson MS, Magee C, Pedersen PL, (2002) Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res 62: 3909-3913.
17. Chen Z, Zhang H, Lu W, Huang P, (2009) Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate. Biochim Biophys Acta 1787: 553-560.
18. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, et al. (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126: 107-120.
19. Penso J, Beitner R, (2002) Clotrimazole decreases glycolysis and the viability of lung carcinoma and colon adenocarcinoma cells. EurJPharmacol 451: 227-235.
20. Glass-Marmor L, Morgenstern H, Beitner R, (1996) Calmodulin antagonists decrease glucose 1,6-bisphosphate, fructose 1,6-bisphosphate, ATP and viability of melanoma cells. EurJPharmacol 313: 265-271.
21. Shaw RJ, (2006) Glucose metabolism and cancer. Current Opinion in Cell Biology 18: 598-608.
22. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, et al. (2006) p53 regulates mitochondrial respiration. Science 312: 1650-1653.
23. Kim JW, Dang CV, (2006) Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 66: 8927-8930.
24. Tong X, Zhao F, Thompson CB, (2009) The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr Opin Genet Dev 19: 32-37.
25. Boros LG, Torday JS, Lim S, Bassilian S, Cascante M, et al. (2000) Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells. Cancer Res 60: 1183-1185.
26. Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, et al. (2005) ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8: 311-321.
27. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, et al. (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452: 230-233.
28. Liu YC, Li F, Handler J, Huang CR, Xiang Y, et al. (2008) Global regulation of nucleotide biosynthetic genes by c-Myc. PLoS ONE 3: e2722.
29. Mannava S, Grachtchouk V, Wheeler LJ, Im M, Zhuang D, et al. (2008) Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells. Cell Cycle 7: 2392-2400.
30. Ko YH, Smith BL, Wang Y, Pomper MG, Rini DA, et al. (2004) Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem Biophys Res Commun 324: 269-275.
31. Fantin VR, St-Pierre J, Leder P, (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9: 425-434.
32. Telang S, Yalcin A, Clem AL, Bucala R, Lane AN, et al. (2006) Ras transformation requires metabolic control by 6-phosphofructo-2-kinase. Oncogene 25: 7225-7234.
33. Kim JW, Gao P, Liu YC, Semenza GL, Dang CV, (2007) Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol 27: 7381-7393.
34. El-Bacha T, de Freitas MS, Sola-Penna M, (2003) Cellular distribution of phosphofructokinase activity and implications to metabolic regulation in human breast cancer. MolGenetMetab 79: 294-299.
35. Tong X, Zhao F, Mancuso A, Gruber JJ, Thompson CB, (2009) The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation. Proc Natl Acad Sci U S A 106: 21660-21665.
36. Gatenby RA, Gillies RJ, (2004) Why do cancers have high aerobic glycolysis? NatRevCancer 4: 891-899.
37. Ouadid-Ahidouch H, Roudbaraki M, Ahidouch A, Delcourt P, Prevarskaya N, (2004) Cell-cycle-dependent expression of the large Ca2+-activated K+ channels in breast cancer cells. Biochem Biophys Res Commun 316: 244-251.
38. Khaitan D, Sankpal UT, Weksler B, Meister EA, Romero IA, et al. (2009) Role of KCNMA1 gene in breast cancer invasion and metastasis to brain. BMC Cancer 9: 258.
39. Zhang W, Ramamoorthy Y, Kilicarslan T, Nolte H, Tyndale RF, et al. (2002) Inhibition of cytochromes P450 by antifungal imidazole derivatives. Drug Metab Dispos 30: 314-318.
40. Wulff H, Miller MJ, Hansel W, Grissmer S, Cahalan MD, et al. (2000) Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci U S A 97: 8151-8156.
41. Abdullaev IF, Rudkouskaya A, Mongin AA, Kuo YH, (2010) Calcium-activated potassium channels BK and IK1 are functionally expressed in human gliomas but do not regulate cell proliferation. PLoS ONE 5: e12304.
42. Garland JM, Halestrap A, (1997) Energy metabolism during apoptosis. Bcl-2 promotes survival in hematopoietic cells induced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrest. JBiolChem 272: 4680-4688.
43. Gonin-Giraud S, Mathieu AL, Diocou S, Tomkowiak M, Delorme G, et al. (2002) Decreased glycolytic metabolism contributes to but is not the inducer of apoptosis following IL-3-starvation. Cell Death Differ 9: 1147-1157.
44. Oddis CV, Finkel MS, (1995) Cytokine-stimulated nitric oxide production inhibits mitochondrial activity in cardiac myocytes. Biochem Biophys Res Commun 213: 1002-1009.
45. Spitz GA, Furtado CM, Sola-Penna M, Zancan P, (2009) Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity. Biochemical Pharmacology 77: 46-53.
46. Kennelly KP, Wallace DM, Holmes TM, Hankey DJ, Grant TS, et al. (2011) Preparation of pre-confluent retinal cells increases graft viability in vitro and in vivo: a mouse model. PLoS ONE 6: e21365.
47. Schwartz MK, Bodansky O, (1968) Utilization of automation for studies of enzyme kinetics. Methods Biochem Anal 16: 183-218.
48. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, (1951) Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193: 265-275.
49. Coelho WS, Costa KC, Sola-Penna M, (2007) Serotonin stimulates mouse skeletal muscle 6-phosphofructo-1-kinase through tyrosine-phosphorylation of the enzyme altering its intracellular localization. MolGenetMetab 92: 364-370.
50. Leite TC, Coelho RG, Silva DD, Coelho WS, Marinho-Carvalho MM, et al. (2011) Lactate downregulates the glycolytic enzymes hexokinase and phosphofructokinase in diverse tissues from mice. FEBS Letters 585: 92-98.
51. Sola-Penna M, Meyer-Fernandes JR, (1998) Stabilization against thermal inactivation promoted by sugars on enzyme structure and function: why is trehalose more effective than other sugars? ArchBiochemBiophys 360: 10-14.
52. Liang C-C, Park AY, Guan J-L, (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nature Protocols 2: 329-333.
53. Chan SW, Lim CJ, Guo K, Ng CP, Lee I, et al. (2008) A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res 68: 2592-2598.